May 14, 2012

Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV

This drug will compete against raltegravir (Merck) and elvitegravir (Gilead).  It will be dosed once a day for treatment naive patients and twice a day for […]
May 11, 2012

Visit our Site

May 11, 2012

Drug Testing of HIV+ Employees and Athletes: What to Do if You Get a False Positive for Marijuana?

Anti-retroviral treatment & sports dopingApr 1, 2012 Hi,if a person who was taking anti retroviral drugs were subject to a sports doping test (but is not […]
May 10, 2012

Possible Label Indication for Truvada as a Prevention Pill for HIV